Pharmaceutical

Kidney

Health Canada Approves Ozempic for Kidney Health


Health Canada has recently authorized Ozempic to help lower the risk of worsening kidney function in individuals with Type 2 diabetes, marking a significant advancement in managing this chronic condition.

Semaglutide

Novo Nordisk Lawsuits Target Semaglutide Copies


Danish pharmaceutical giant Novo Nordisk has intensified its legal battle against the sale of unapproved versions of semaglutide, the key ingredient in its blockbuster weight-loss and diabetes drugs

Decongestant

Avoid These Mistakes While Taking a Decongestant


A stuffy nose from a cold, flu, or allergies can be bothersome, but over-the-counter (OTC) decongestants like pseudoephedrine (Sudafed), phenylephrine (Sudafed PE, Neo-Synephrine), and oxymetazoline (Afrin) offer quick relief. However, improper use can lead to...

Tariffs

Canadian Pharma Faces Uncertainty with US Tariffs


The recent announcement by President Donald Trump regarding the imposition of a 25% tariff on all imported goods, including pharmaceuticals, has raised significant concerns within the Canadian pharmaceutical manufacturing industry.

Drug

Improving Drug Adherence for Older Patients


Medication or Drug adherence refers to the extent to which a person’s medication-taking behavior aligns with the recommendations provided by their healthcare provider. Adherence to medications averages around 50% among patients with chronic diseases. This...

Cancer

The Financial Burden of Cancer in Canada


A recent report highlights a stark reality faced by cancer patients in Canada: the financial toll of cancer extends far beyond medical treatments. On average, individuals with cancer incur nearly $33,000 in out-of-pocket expenses during...

Dementia and the Impact of Certain Medications


Recent data presented at the American Geriatrics Society (AGS) 2024 Annual Scientific Meeting highlights the widespread use of medications that negatively affect cognition among older adults with dementia. The study analyzed data from approximately 13...